Ashaunta T. Anderson
50 Studies Every Pediatrician Should Know
Ashaunta T. Anderson
50 Studies Every Pediatrician Should Know
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
50 Studies Every Pediatrician Should Know presents summaries of key studies that have shaped the current clinical practice of pediatrics. Numerous subspecialties are covered, including cardiology and neonatology. An illustrative clinical case concludes each review, followed by brief information on other relevant studies.
Andere Kunden interessierten sich auch für
- 50 Studies Every Neurologist Should Know61,99 €
- 50 Studies Every Psychiatrist Should Know58,99 €
- 50 Studies Every Internist Should Know61,99 €
- Understanding and Cultivating Well-being for the Pediatrician53,99 €
- Jörg Wilhelm OestmannDie 50 wichtigsten Fälle Bildgebende Verfahren30,00 €
- 50 Fälle Pädiatrie33,00 €
- Nicolas GumpertDie 50 wichtigsten Fälle Orthopädie32,00 €
-
-
-
50 Studies Every Pediatrician Should Know presents summaries of key studies that have shaped the current clinical practice of pediatrics. Numerous subspecialties are covered, including cardiology and neonatology. An illustrative clinical case concludes each review, followed by brief information on other relevant studies.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: OUP US
- Seitenzahl: 360
- Erscheinungstermin: 31. Mai 2016
- Englisch
- Abmessung: 234mm x 156mm x 19mm
- Gewicht: 547g
- ISBN-13: 9780190204037
- ISBN-10: 0190204036
- Artikelnr.: 47863341
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
- Verlag: OUP US
- Seitenzahl: 360
- Erscheinungstermin: 31. Mai 2016
- Englisch
- Abmessung: 234mm x 156mm x 19mm
- Gewicht: 547g
- ISBN-13: 9780190204037
- ISBN-10: 0190204036
- Artikelnr.: 47863341
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
Ashaunta T. Anderson is a Robert Wood Johnson Clinical Scholar at the University of California in Los Angeles, California. Nina L. Shapiro is the Director of Pediatric Otolaryngology and an Associate Professor of Head and Neck Surgery at the UCLA David Geffen School of Medicine in Los Angeles, California. Stephen C. Aronoff is the Waldo E. Nelson Professor and Chairman of Pediatrics at Temple University in Philadelphia, Pennsylvania. Jeremiah Davis is a Pediatric Resident at Seattle Children's Hospital and the University of Washington in Seattle, Washington. Michael Levy is a Pediatric Clinical Lecturer at the University of Michigan and C.S. Mott Children's Hospital which in Ann Arbor, Michigan.
* Section I: Allergy Immunology
* 1. Efficacy of Immunoglobulin Plus Prednisolone in Prevention of
Coronary Artery Abnormalities in Kawasaki Disease
* Section II: Behavioral
* 2. Measles, Mumps, and Rubella Vaccination and Autism
* 3. Treatment for adolescents with depression study (TADS)
* 4. The Multimodal Treatment Study of Children with Attention
Deficit/Hyperactivity Disorder (MTA)
* Section III: Cardiology
* 5. Pharmacologic Closure of a Patent Ductus Arteriosus in Premature
Infants
* 6. The relation of overweight to cardiovascular risk factors among
children and adolescents: the Bogalusa heart study
* Section IV: Dermatology
* 7. Propranolol vs. Prednisolone for Symptomatic Proliferating
Infantile Hemangiomas: A Randomized Clinical Trial
* Section V: Endocrinology
* 8. Risk Factors for Cerebral Edema in Children with Diabetic
Ketoacidosis
* Section VI: ENT
* 9. A Trial of Early Ear Tube Placement in Children with Persistent
Otitis Media
* Section VII: General Pediatrics
* 10. Maintenance IV Fluid Requirements
* 11. Predischarge Serum Bilirubin to Predict Significant
Hyperbilirubinemia in Newborns
* 12. Sudden Infant Death Syndrome Risk Factors: The Chicago Infant
Mortality Study
* 13. Treatment of Acute Otitis Media in Children
* 14. The Human Papillomavirus Vaccine
* 15. Evidence of Decrease in Vaccine-Type Human Papillomavirus (HPV)
and Herd Protection in Adolescents and Young Women
* 16. Effects of Lead Exposure in Childhood
* Section VIII: Hematology
* 17. Iron Supplementation for Breastfed Infants
* 18. Transfusion Strategies for Patients in Pediatric Intensive Care
Units
* 19. Prophylactic Penicillin in Sickle Cell Anemia
* Section IX: Infectious Disease
* 20. Empiric Antimicrobial Therapy for Skin and Soft-Tissue Infections
* 21. Infants at Low Risk for Serious Bacterial Infection
* 22. Outpatient Treatment of Febrile Infants at Low Risk for Serious
Bacterial Infection
* 23. Outpatient Treatment of Selected Febrile Infants Without
Antibiotics
* 24. Neonatal Fever Without a Source
* 25. Serious Bacterial Infections and Viral Infections in Febrile
Infants
* 26. Chest Radiograph and Lower Respiratory Tract Infection
* 27. Vidarabine Therapy of Neonatal Herpes Simplex Virus Infection
* 28. Early Reversal of Pediatric and Neonatal Septic Shock
* 29. Reduction of vertical transmission of human immunodeficiency
virus (HIV)
* 30. Palivizumab prophylaxis against Respiratory Syncytial Virus (RSV)
in high risk infants
* 31. The Spectrum of Bronchiolitis
* 32. Preventing Early-Onset Neonatal Group B Streptococcal Disease
* Section X: Neonatology
* 33. Apgar Scoring of Infants at Delivery
* 34. Prophylactic Treatment with Human Surfactant in Extremely Preterm
Infants
* Section XI: Nephrology
* 35. Oral versus Initial Intravenous Antibiotics for Urinary Tract
Infection in Young Febrile Children
* 36. Identifying children with minimal change disease (MCD)
* 37. Chronic renal disease following poststreptococcal
glomerulonephritis
* Section XII: Neurology
* 38. Antipyretic Agents for Preventing Febrile Seizure Recurrence
* 39. Febrile Seizures and Risk for Epilepsy
* 40. Seizure Recurrence After First Unprovoked Afebrile Seizure
* 41. Mortality and Childhood-Onset Epilepsy
* 42. Identifying Children with Low-Risk Head Injuries Who Do Not
Require Computed Tomography
* Section XIII: Oncology
* 43. Health-Related Quality of Life Among Children with Acute
Lymphoblastic Leukemia
* Section XIV: Ophthalmology
* 44. Treatment of Acute Conjunctivitis in Children
* 45. Screening for Amblyopia
* Section XV: Orthopedics
* 46. Differentiation Between Septic Arthritis and Transient Synovitis
of the Hip in Children
* Section XVI: Pulmonary
* 47. Steroids for the Treatment of Croup
* 48. Inhaled Corticosteroids for Mild Persistent Asthma
* 49. Inhaled Salbutamol (Albuterol) vs. Injected Epinephrine in Acute
Asthma
* 50. Long-term Inhaled Hypertonic Saline for Cystic Fibrosis
* 1. Efficacy of Immunoglobulin Plus Prednisolone in Prevention of
Coronary Artery Abnormalities in Kawasaki Disease
* Section II: Behavioral
* 2. Measles, Mumps, and Rubella Vaccination and Autism
* 3. Treatment for adolescents with depression study (TADS)
* 4. The Multimodal Treatment Study of Children with Attention
Deficit/Hyperactivity Disorder (MTA)
* Section III: Cardiology
* 5. Pharmacologic Closure of a Patent Ductus Arteriosus in Premature
Infants
* 6. The relation of overweight to cardiovascular risk factors among
children and adolescents: the Bogalusa heart study
* Section IV: Dermatology
* 7. Propranolol vs. Prednisolone for Symptomatic Proliferating
Infantile Hemangiomas: A Randomized Clinical Trial
* Section V: Endocrinology
* 8. Risk Factors for Cerebral Edema in Children with Diabetic
Ketoacidosis
* Section VI: ENT
* 9. A Trial of Early Ear Tube Placement in Children with Persistent
Otitis Media
* Section VII: General Pediatrics
* 10. Maintenance IV Fluid Requirements
* 11. Predischarge Serum Bilirubin to Predict Significant
Hyperbilirubinemia in Newborns
* 12. Sudden Infant Death Syndrome Risk Factors: The Chicago Infant
Mortality Study
* 13. Treatment of Acute Otitis Media in Children
* 14. The Human Papillomavirus Vaccine
* 15. Evidence of Decrease in Vaccine-Type Human Papillomavirus (HPV)
and Herd Protection in Adolescents and Young Women
* 16. Effects of Lead Exposure in Childhood
* Section VIII: Hematology
* 17. Iron Supplementation for Breastfed Infants
* 18. Transfusion Strategies for Patients in Pediatric Intensive Care
Units
* 19. Prophylactic Penicillin in Sickle Cell Anemia
* Section IX: Infectious Disease
* 20. Empiric Antimicrobial Therapy for Skin and Soft-Tissue Infections
* 21. Infants at Low Risk for Serious Bacterial Infection
* 22. Outpatient Treatment of Febrile Infants at Low Risk for Serious
Bacterial Infection
* 23. Outpatient Treatment of Selected Febrile Infants Without
Antibiotics
* 24. Neonatal Fever Without a Source
* 25. Serious Bacterial Infections and Viral Infections in Febrile
Infants
* 26. Chest Radiograph and Lower Respiratory Tract Infection
* 27. Vidarabine Therapy of Neonatal Herpes Simplex Virus Infection
* 28. Early Reversal of Pediatric and Neonatal Septic Shock
* 29. Reduction of vertical transmission of human immunodeficiency
virus (HIV)
* 30. Palivizumab prophylaxis against Respiratory Syncytial Virus (RSV)
in high risk infants
* 31. The Spectrum of Bronchiolitis
* 32. Preventing Early-Onset Neonatal Group B Streptococcal Disease
* Section X: Neonatology
* 33. Apgar Scoring of Infants at Delivery
* 34. Prophylactic Treatment with Human Surfactant in Extremely Preterm
Infants
* Section XI: Nephrology
* 35. Oral versus Initial Intravenous Antibiotics for Urinary Tract
Infection in Young Febrile Children
* 36. Identifying children with minimal change disease (MCD)
* 37. Chronic renal disease following poststreptococcal
glomerulonephritis
* Section XII: Neurology
* 38. Antipyretic Agents for Preventing Febrile Seizure Recurrence
* 39. Febrile Seizures and Risk for Epilepsy
* 40. Seizure Recurrence After First Unprovoked Afebrile Seizure
* 41. Mortality and Childhood-Onset Epilepsy
* 42. Identifying Children with Low-Risk Head Injuries Who Do Not
Require Computed Tomography
* Section XIII: Oncology
* 43. Health-Related Quality of Life Among Children with Acute
Lymphoblastic Leukemia
* Section XIV: Ophthalmology
* 44. Treatment of Acute Conjunctivitis in Children
* 45. Screening for Amblyopia
* Section XV: Orthopedics
* 46. Differentiation Between Septic Arthritis and Transient Synovitis
of the Hip in Children
* Section XVI: Pulmonary
* 47. Steroids for the Treatment of Croup
* 48. Inhaled Corticosteroids for Mild Persistent Asthma
* 49. Inhaled Salbutamol (Albuterol) vs. Injected Epinephrine in Acute
Asthma
* 50. Long-term Inhaled Hypertonic Saline for Cystic Fibrosis
* Section I: Allergy Immunology
* 1. Efficacy of Immunoglobulin Plus Prednisolone in Prevention of
Coronary Artery Abnormalities in Kawasaki Disease
* Section II: Behavioral
* 2. Measles, Mumps, and Rubella Vaccination and Autism
* 3. Treatment for adolescents with depression study (TADS)
* 4. The Multimodal Treatment Study of Children with Attention
Deficit/Hyperactivity Disorder (MTA)
* Section III: Cardiology
* 5. Pharmacologic Closure of a Patent Ductus Arteriosus in Premature
Infants
* 6. The relation of overweight to cardiovascular risk factors among
children and adolescents: the Bogalusa heart study
* Section IV: Dermatology
* 7. Propranolol vs. Prednisolone for Symptomatic Proliferating
Infantile Hemangiomas: A Randomized Clinical Trial
* Section V: Endocrinology
* 8. Risk Factors for Cerebral Edema in Children with Diabetic
Ketoacidosis
* Section VI: ENT
* 9. A Trial of Early Ear Tube Placement in Children with Persistent
Otitis Media
* Section VII: General Pediatrics
* 10. Maintenance IV Fluid Requirements
* 11. Predischarge Serum Bilirubin to Predict Significant
Hyperbilirubinemia in Newborns
* 12. Sudden Infant Death Syndrome Risk Factors: The Chicago Infant
Mortality Study
* 13. Treatment of Acute Otitis Media in Children
* 14. The Human Papillomavirus Vaccine
* 15. Evidence of Decrease in Vaccine-Type Human Papillomavirus (HPV)
and Herd Protection in Adolescents and Young Women
* 16. Effects of Lead Exposure in Childhood
* Section VIII: Hematology
* 17. Iron Supplementation for Breastfed Infants
* 18. Transfusion Strategies for Patients in Pediatric Intensive Care
Units
* 19. Prophylactic Penicillin in Sickle Cell Anemia
* Section IX: Infectious Disease
* 20. Empiric Antimicrobial Therapy for Skin and Soft-Tissue Infections
* 21. Infants at Low Risk for Serious Bacterial Infection
* 22. Outpatient Treatment of Febrile Infants at Low Risk for Serious
Bacterial Infection
* 23. Outpatient Treatment of Selected Febrile Infants Without
Antibiotics
* 24. Neonatal Fever Without a Source
* 25. Serious Bacterial Infections and Viral Infections in Febrile
Infants
* 26. Chest Radiograph and Lower Respiratory Tract Infection
* 27. Vidarabine Therapy of Neonatal Herpes Simplex Virus Infection
* 28. Early Reversal of Pediatric and Neonatal Septic Shock
* 29. Reduction of vertical transmission of human immunodeficiency
virus (HIV)
* 30. Palivizumab prophylaxis against Respiratory Syncytial Virus (RSV)
in high risk infants
* 31. The Spectrum of Bronchiolitis
* 32. Preventing Early-Onset Neonatal Group B Streptococcal Disease
* Section X: Neonatology
* 33. Apgar Scoring of Infants at Delivery
* 34. Prophylactic Treatment with Human Surfactant in Extremely Preterm
Infants
* Section XI: Nephrology
* 35. Oral versus Initial Intravenous Antibiotics for Urinary Tract
Infection in Young Febrile Children
* 36. Identifying children with minimal change disease (MCD)
* 37. Chronic renal disease following poststreptococcal
glomerulonephritis
* Section XII: Neurology
* 38. Antipyretic Agents for Preventing Febrile Seizure Recurrence
* 39. Febrile Seizures and Risk for Epilepsy
* 40. Seizure Recurrence After First Unprovoked Afebrile Seizure
* 41. Mortality and Childhood-Onset Epilepsy
* 42. Identifying Children with Low-Risk Head Injuries Who Do Not
Require Computed Tomography
* Section XIII: Oncology
* 43. Health-Related Quality of Life Among Children with Acute
Lymphoblastic Leukemia
* Section XIV: Ophthalmology
* 44. Treatment of Acute Conjunctivitis in Children
* 45. Screening for Amblyopia
* Section XV: Orthopedics
* 46. Differentiation Between Septic Arthritis and Transient Synovitis
of the Hip in Children
* Section XVI: Pulmonary
* 47. Steroids for the Treatment of Croup
* 48. Inhaled Corticosteroids for Mild Persistent Asthma
* 49. Inhaled Salbutamol (Albuterol) vs. Injected Epinephrine in Acute
Asthma
* 50. Long-term Inhaled Hypertonic Saline for Cystic Fibrosis
* 1. Efficacy of Immunoglobulin Plus Prednisolone in Prevention of
Coronary Artery Abnormalities in Kawasaki Disease
* Section II: Behavioral
* 2. Measles, Mumps, and Rubella Vaccination and Autism
* 3. Treatment for adolescents with depression study (TADS)
* 4. The Multimodal Treatment Study of Children with Attention
Deficit/Hyperactivity Disorder (MTA)
* Section III: Cardiology
* 5. Pharmacologic Closure of a Patent Ductus Arteriosus in Premature
Infants
* 6. The relation of overweight to cardiovascular risk factors among
children and adolescents: the Bogalusa heart study
* Section IV: Dermatology
* 7. Propranolol vs. Prednisolone for Symptomatic Proliferating
Infantile Hemangiomas: A Randomized Clinical Trial
* Section V: Endocrinology
* 8. Risk Factors for Cerebral Edema in Children with Diabetic
Ketoacidosis
* Section VI: ENT
* 9. A Trial of Early Ear Tube Placement in Children with Persistent
Otitis Media
* Section VII: General Pediatrics
* 10. Maintenance IV Fluid Requirements
* 11. Predischarge Serum Bilirubin to Predict Significant
Hyperbilirubinemia in Newborns
* 12. Sudden Infant Death Syndrome Risk Factors: The Chicago Infant
Mortality Study
* 13. Treatment of Acute Otitis Media in Children
* 14. The Human Papillomavirus Vaccine
* 15. Evidence of Decrease in Vaccine-Type Human Papillomavirus (HPV)
and Herd Protection in Adolescents and Young Women
* 16. Effects of Lead Exposure in Childhood
* Section VIII: Hematology
* 17. Iron Supplementation for Breastfed Infants
* 18. Transfusion Strategies for Patients in Pediatric Intensive Care
Units
* 19. Prophylactic Penicillin in Sickle Cell Anemia
* Section IX: Infectious Disease
* 20. Empiric Antimicrobial Therapy for Skin and Soft-Tissue Infections
* 21. Infants at Low Risk for Serious Bacterial Infection
* 22. Outpatient Treatment of Febrile Infants at Low Risk for Serious
Bacterial Infection
* 23. Outpatient Treatment of Selected Febrile Infants Without
Antibiotics
* 24. Neonatal Fever Without a Source
* 25. Serious Bacterial Infections and Viral Infections in Febrile
Infants
* 26. Chest Radiograph and Lower Respiratory Tract Infection
* 27. Vidarabine Therapy of Neonatal Herpes Simplex Virus Infection
* 28. Early Reversal of Pediatric and Neonatal Septic Shock
* 29. Reduction of vertical transmission of human immunodeficiency
virus (HIV)
* 30. Palivizumab prophylaxis against Respiratory Syncytial Virus (RSV)
in high risk infants
* 31. The Spectrum of Bronchiolitis
* 32. Preventing Early-Onset Neonatal Group B Streptococcal Disease
* Section X: Neonatology
* 33. Apgar Scoring of Infants at Delivery
* 34. Prophylactic Treatment with Human Surfactant in Extremely Preterm
Infants
* Section XI: Nephrology
* 35. Oral versus Initial Intravenous Antibiotics for Urinary Tract
Infection in Young Febrile Children
* 36. Identifying children with minimal change disease (MCD)
* 37. Chronic renal disease following poststreptococcal
glomerulonephritis
* Section XII: Neurology
* 38. Antipyretic Agents for Preventing Febrile Seizure Recurrence
* 39. Febrile Seizures and Risk for Epilepsy
* 40. Seizure Recurrence After First Unprovoked Afebrile Seizure
* 41. Mortality and Childhood-Onset Epilepsy
* 42. Identifying Children with Low-Risk Head Injuries Who Do Not
Require Computed Tomography
* Section XIII: Oncology
* 43. Health-Related Quality of Life Among Children with Acute
Lymphoblastic Leukemia
* Section XIV: Ophthalmology
* 44. Treatment of Acute Conjunctivitis in Children
* 45. Screening for Amblyopia
* Section XV: Orthopedics
* 46. Differentiation Between Septic Arthritis and Transient Synovitis
of the Hip in Children
* Section XVI: Pulmonary
* 47. Steroids for the Treatment of Croup
* 48. Inhaled Corticosteroids for Mild Persistent Asthma
* 49. Inhaled Salbutamol (Albuterol) vs. Injected Epinephrine in Acute
Asthma
* 50. Long-term Inhaled Hypertonic Saline for Cystic Fibrosis